Evista (chemical name: raloxifene) is a SERM approved by the U.S. Food and Drug Administration (FDA) to: 1  reduce the risk of hormone-receptor-positive breast cancer in postmenopausal women who haven't been diagnosed but are at higher-than-average risk for disease.
Types of paper ICT Express publishes original research papers in English in the fields of ICT convergence, platform technologies, communication networks, and device technologies. ICT Express accepts short-length (up to 4 pages in double columns and additional 2 pages will be allowed with over page charge (100USD/1page)) high-quality, original articles in Latex or Word format. Sample manuscript can be downloaded here.
Include the same information as a regular book. Add as much as the original publication information as possible. After citing the original publication information, add the electronic publication information.This includes the title of the internet site, the editor of the site (if given), the date of electronic publication (if given), and the sponsoring institution or organization.nclude the same information as a regular book. Add as much as the original publication information as possible. After citing the original publication information, add the electronic publication information.